Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2
Condition(s):Skin Structures and Soft Tissue InfectionsLast Updated:August 7, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Skin Structures and Soft Tissue InfectionsLast Updated:August 7, 2018Completed
Condition(s):Skin Structures and Soft Tissue InfectionsLast Updated:June 19, 2018Completed
Condition(s):Hospital-Acquired Pneumonia; Ventilator-Associated Pneumonia; Health-Care-Associated PneumoniaLast Updated:February 13, 2009Terminated
Condition(s):Complicated Skin and Skin Structure InfectionLast Updated:April 4, 2008Completed
Condition(s):Skin Diseases, BacterialLast Updated:March 27, 2007Completed
Condition(s):Dermatitis, AtopicLast Updated:December 11, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.